Healthcare >> CEO Interviews >> January 10, 2001
DR. WILLIAM A. HASELTINE is Chairman of the Board of Directors and Chief
Executive Officer of Human Genome Sciences, Inc., (HGS), a company he
founded in 1992. Human Genome Sciences' mission is to develop products
to prevent, treat and cure disease based on its leadership in the
discovery and understanding of human genes.William A. Haseltine holds a
doctorate from Harvard University in Biophysics. Dr. Haseltine was a
Professor at Dana-Farber Cancer Institute, Harvard Medical School and
Harvard School of Public Health from 1976 to 1993. Dr. Haseltine became
Chairman and CEO of HGS in 1993. He has a distinguished record of
achievement in cancer and AIDS research and has received numerous awards
for his scientific work. He is the founder and Editor of the journal, E-
Biomed: The Journal of Regenerative Medicine. Dr. Haseltine is the
Chairman of the Board of Trustees of the National Health Museum, a
member of the Brookings Institution Board of Trustees as well as a
trustee for the Committee for Economic Development. He has over 250
publications in scientific literature and has been awarded more than 50
patents for his discoveries. Dr. Haseltine also has many years of
experience with biotechnology companies. Since 1981, he has founded
seven companies, each in a different area of medicine. As a scientific
advisor to HealthCare Ventures, he helped to establish an additional 20
biotechnology companies. Dr. Haseltine has received many honors for his
achievements in science, medicine and business. Profile
Genome Sciences?
Dr. Haseltine: Human Genome Sciences was formed in the summer of 1992,
and we opened our doors for
